BUDA (NYSEAMERICAN:BUDA) Stock Bumped Up to “Hold” by Zacks Research

BUDA (NYSEAMERICAN:BUDA – Get Free Report) was upgraded by equities research analysts at Zacks Research to a “hold” rating in a research note issued to investors on Tuesday, Zacks reports.

Separately, Roth Capital started coverage on BUDA in a research report on Monday. They issued a “buy” rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, BUDA presently has a consensus rating of “Moderate Buy” and an average price target of $13.00.

Check Out Our Latest Analysis on BUDA

BUDA Stock Up 3.9%

BUDA opened at $8.20 on Tuesday. The company has a fifty day moving average of $8.17 and a 200 day moving average of $8.93. BUDA has a fifty-two week low of $6.25 and a fifty-two week high of $12.00.

BUDA (NYSEAMERICAN:BUDA – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported $0.04 EPS for the quarter. The company had revenue of $4.51 million during the quarter. Sell-side analysts predict that BUDA will post 0.11 earnings per share for the current year.

BUDA Company Profile

(Get Free Report)

Buda Juice, Inc (NYSE American: BUDA) is a beverage company focused on producing and selling organic, cold-pressed juice products. Its offerings are designed to provide convenient, ready-to-consume beverages made from fruit, vegetables and other plant-based ingredients.

The company’s product portfolio includes cold-pressed juice shots and related functional beverage products, with formulations intended to support wellness and everyday nutrition. Buda Juice products are marketed through retail, natural and specialty food channels, as well as other distribution outlets.

Buda Juice serves consumers seeking refrigerated, minimally processed and plant-based beverage options.

Further Reading

Receive News & Ratings for BUDA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BUDA and related companies with MarketBeat.com's FREE daily email newsletter.